论文部分内容阅读
目的分析卡贝缩宫素与卡前列甲酯栓联合应用于剖宫产产妇的止血效果。方法选取2011年8月—2012年11月,我院相关科室收治的剖宫产产妇80例为研究对象,并将其随机分成二组,对照组40例产妇给予缩宫素处理,观察组40例产妇则以卡贝缩宫素与卡前列甲酯栓联合处理。对二组产妇术中与术后的出血量、不良反应情况进行对比分析。结果对照组产妇无论是术中出血量还是术后出血量均明显多于观察组产妇,比较二组差异具有统计学意义(P<0.05);对照组产妇肛门排气时间长于观察组,组间差异有统计学意义(P<0.05)。二组产妇在临床不良反应方面差异无统计学意义(P>0.05)。结论相比于缩宫素处理,卡贝缩宫素与卡前列甲酯栓联合应用于剖宫产产妇的止血效果更佳,且产妇的临床不良反应少,安全性高,值得应用。
Objective To analyze the hemostatic effect of combination of carbetocin and card top methyl ester suppository on cesarean section maternal. Methods From August 2011 to November 2012, 80 cases of caesarean section in our department were divided into two groups randomly. Forty cases of control group were treated with oxytocin, while observation group 40 Cases of mothers in order to carbetocin and card thiosulfate suppository treatment. The two groups of maternal postoperative bleeding and postoperative adverse reactions were compared. Results Compared with the observation group, the bleeding rate of the control group was significantly higher than that of the observation group (P <0.05). The anal exhaust time of the control group was longer than that of the observation group and between the two groups The difference was statistically significant (P <0.05). The two groups of maternal differences in clinical adverse reactions was not statistically significant (P> 0.05). Conclusions Compared with oxytocin treatment, carbetocin and carbamazepin suppository combined with cesarean section maternal hemostatic effect is better, and the maternal clinical adverse reactions less safe and worthy of application.